Selected research
Market Structure
Global Topical Steroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Topical Steroids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Topical Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Steroids include Abbott, Sanofi, Novartis, Merck, Roche, Eli Lilly, Pfizer, Glaxosmithkline and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Topical Steroids output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Topical Steroids by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Topical Steroids market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Topical Steroids and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Topical Steroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Steroids market size, projected growth trends, production technologies, key applications, and end-use industries.
Topical Steroids Segment by Company
Abbott
Sanofi
Novartis
Merck
Roche
Eli Lilly
Pfizer
Glaxosmithkline
Bayer
Taro Pharmaceuticals U.S.A.
Taro Pharmaceuticals
Pure Tek
Nu Care Pharmaceuticals
Galderma
Arbor Pharmaceuticals
Aqua Pharmaceuticals
Apotex
Topical Steroids Segment by Type
Class III
Class II
Class IV
Class I
Class VII
Class VI
Class V
Topical Steroids Segment by Application
Treatment of Dermatitis
Treatment of Rash
Treatment of Eczema
Topical Steroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Steroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Steroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Steroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Topical Steroids market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Steroids industry.
Chapter 3: Detailed analysis of Topical Steroids market competition landscape. Including Topical Steroids manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Topical Steroids by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Topical Steroids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Class III
- Class II
- Class IV
- Class I
- Class VII
- Class VI
- Class V
Applications
- Treatment of Dermatitis
- Treatment of Rash
- Treatment of Eczema
Companies covered
- Abbott
- Sanofi
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- Glaxosmithkline
- Bayer
- Taro Pharmaceuticals U.S.A.
- Taro Pharmaceuticals
- Pure Tek
- Nu Care Pharmaceuticals
- Galderma
- Arbor Pharmaceuticals
- Aqua Pharmaceuticals
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Topical Steroids Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Topical Steroids Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Topical Steroids Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Topical Steroids Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Topical Steroids Market Dynamics
- 2.1 Topical Steroids Industry Trends
- 2.2 Topical Steroids Industry Drivers
- 2.3 Topical Steroids Industry Opportunities and Challenges
- 2.4 Topical Steroids Industry Restraints
3 Topical Steroids Market by Manufacturers
- 3.1 Global Topical Steroids Production Value by Manufacturers (2021-2026)
- 3.2 Global Topical Steroids Production by Manufacturers (2021-2026)
- 3.3 Global Topical Steroids Average Price by Manufacturers (2021-2026)
- 3.4 Global Topical Steroids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Topical Steroids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Topical Steroids Manufacturers, Product Type & Application
- 3.7 Global Topical Steroids Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Topical Steroids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Topical Steroids Players Market Share by Production Value in 2025
- 3.8.3 2025 Topical Steroids Tier 1, Tier 2, and Tier 3
4 Topical Steroids Market by Type
- 4.1 Topical Steroids Type Introduction
- 4.1.1 Class III
- 4.1.2 Class II
- 4.1.3 Class IV
- 4.1.4 Class I
- 4.1.5 Class VII
- 4.1.6 Class VI
- 4.1.7 Class V
- 4.2 Global Topical Steroids Production by Type
- 4.2.1 Global Topical Steroids Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Topical Steroids Production by Type (2021-2032)
- 4.2.3 Global Topical Steroids Production Market Share by Type (2021-2032)
- 4.3 Global Topical Steroids Production Value by Type
- 4.3.1 Global Topical Steroids Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Topical Steroids Production Value by Type (2021-2032)
- 4.3.3 Global Topical Steroids Production Value Market Share by Type (2021-2032)
5 Topical Steroids Market by Application
- 5.1 Topical Steroids Application Introduction
- 5.1.1 Treatment of Dermatitis
- 5.1.2 Treatment of Rash
- 5.1.3 Treatment of Eczema
- 5.2 Global Topical Steroids Production by Application
- 5.2.1 Global Topical Steroids Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Topical Steroids Production by Application (2021-2032)
- 5.2.3 Global Topical Steroids Production Market Share by Application (2021-2032)
- 5.3 Global Topical Steroids Production Value by Application
- 5.3.1 Global Topical Steroids Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Topical Steroids Production Value by Application (2021-2032)
- 5.3.3 Global Topical Steroids Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.1.4 Abbott Topical Steroids Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.2.4 Sanofi Topical Steroids Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.3.4 Novartis Topical Steroids Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.4.4 Merck Topical Steroids Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.5.4 Roche Topical Steroids Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.6.4 Eli Lilly Topical Steroids Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.7.4 Pfizer Topical Steroids Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Glaxosmithkline
- 6.8.1 Glaxosmithkline Company Information
- 6.8.2 Glaxosmithkline Business Overview
- 6.8.3 Glaxosmithkline Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.8.4 Glaxosmithkline Topical Steroids Product Portfolio
- 6.8.5 Glaxosmithkline Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.9.4 Bayer Topical Steroids Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 Taro Pharmaceuticals U.S.A.
- 6.10.1 Taro Pharmaceuticals U.S.A. Company Information
- 6.10.2 Taro Pharmaceuticals U.S.A. Business Overview
- 6.10.3 Taro Pharmaceuticals U.S.A. Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.10.4 Taro Pharmaceuticals U.S.A. Topical Steroids Product Portfolio
- 6.10.5 Taro Pharmaceuticals U.S.A. Recent Developments
- 6.11 Taro Pharmaceuticals
- 6.11.1 Taro Pharmaceuticals Company Information
- 6.11.2 Taro Pharmaceuticals Business Overview
- 6.11.3 Taro Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.11.4 Taro Pharmaceuticals Topical Steroids Product Portfolio
- 6.11.5 Taro Pharmaceuticals Recent Developments
- 6.12 Pure Tek
- 6.12.1 Pure Tek Company Information
- 6.12.2 Pure Tek Business Overview
- 6.12.3 Pure Tek Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.12.4 Pure Tek Topical Steroids Product Portfolio
- 6.12.5 Pure Tek Recent Developments
- 6.13 Nu Care Pharmaceuticals
- 6.13.1 Nu Care Pharmaceuticals Company Information
- 6.13.2 Nu Care Pharmaceuticals Business Overview
- 6.13.3 Nu Care Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.13.4 Nu Care Pharmaceuticals Topical Steroids Product Portfolio
- 6.13.5 Nu Care Pharmaceuticals Recent Developments
- 6.14 Galderma
- 6.14.1 Galderma Company Information
- 6.14.2 Galderma Business Overview
- 6.14.3 Galderma Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.14.4 Galderma Topical Steroids Product Portfolio
- 6.14.5 Galderma Recent Developments
- 6.15 Arbor Pharmaceuticals
- 6.15.1 Arbor Pharmaceuticals Company Information
- 6.15.2 Arbor Pharmaceuticals Business Overview
- 6.15.3 Arbor Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.15.4 Arbor Pharmaceuticals Topical Steroids Product Portfolio
- 6.15.5 Arbor Pharmaceuticals Recent Developments
- 6.16 Aqua Pharmaceuticals
- 6.16.1 Aqua Pharmaceuticals Company Information
- 6.16.2 Aqua Pharmaceuticals Business Overview
- 6.16.3 Aqua Pharmaceuticals Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.16.4 Aqua Pharmaceuticals Topical Steroids Product Portfolio
- 6.16.5 Aqua Pharmaceuticals Recent Developments
- 6.17 Apotex
- 6.17.1 Apotex Company Information
- 6.17.2 Apotex Business Overview
- 6.17.3 Apotex Topical Steroids Production, Value and Gross Margin (2021-2026)
- 6.17.4 Apotex Topical Steroids Product Portfolio
- 6.17.5 Apotex Recent Developments
7 Global Topical Steroids Production by Region
- 7.1 Global Topical Steroids Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Topical Steroids Production by Region (2021-2032)
- 7.2.1 Global Topical Steroids Production by Region (2021-2026)
- 7.2.2 Global Topical Steroids Production Forecast by Region (2027-2032)
- 7.3 Global Topical Steroids Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Topical Steroids Production Value by Region (2021-2032)
- 7.4.1 Global Topical Steroids Production Value by Region (2021-2026)
- 7.4.2 Global Topical Steroids Production Value by Region (2027-2032)
- 7.5 Global Topical Steroids Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Topical Steroids Production Value (2021-2032)
- 7.6.2 Europe Topical Steroids Production Value (2021-2032)
- 7.6.3 Asia-Pacific Topical Steroids Production Value (2021-2032)
- 7.6.4 South America Topical Steroids Production Value (2021-2032)
- 7.6.5 Middle East & Africa Topical Steroids Production Value (2021-2032)
8 Global Topical Steroids Consumption by Region
- 8.1 Global Topical Steroids Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Topical Steroids Consumption by Region (2021-2032)
- 8.2.1 Global Topical Steroids Consumption by Region (2021-2026)
- 8.2.2 Global Topical Steroids Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Topical Steroids Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Topical Steroids Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Topical Steroids Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Topical Steroids Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Topical Steroids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Topical Steroids Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Topical Steroids Value Chain Analysis
- 9.1.1 Topical Steroids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Topical Steroids Production Mode & Process
- 9.2 Topical Steroids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Topical Steroids Distributors
- 9.2.3 Topical Steroids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst